Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium

Biological Psychiatry

Volumn 84, Issue 9, 2018, Pages 644-654

  van Erp, Theo G M ^a   Walton, Esther ^b   Hibar, Derrek P ^c,d   Schmaal, Lianne ^af,ag,at   Jiang, Wenhao ^b   Glahn, David C ^i,j   Pearlson, Godfrey D ^i,j   Yao, Nailin ^i,j   Fukunaga, Masaki ^az   Hashimoto, Ryota ^ba,bb   Okada, Naohiro ^bc   Yamamori, Hidenaga ^bb   Bustillo, Juan R ^k   Clark, Vincent P ^k,l   Agartz, Ingrid ^bd,bf,bg,cu   Mueller, Bryon A ^m   Cahn, Wiepke ^ax   de Zwarte, Sonja M C ^ax   Hulshoff Pol, Hilleke E ^ax   Kahn, René S ^ax   Ophoff, Roel A ^o,ax   van Haren, Neeltje E M ^av,ax   Andreassen, Ole A ^bd,be   Dale, Anders M ^e,f,g,h   Doan, Nhat Trung ^bd   Gurholt, Tiril P ^bd,bf   Hartberg, Cecilie B ^bd   Haukvik, Unn K ^bd,be   Jørgensen, Kjetil N ^bd,bf   Lagerberg, Trine V ^be   Melle, Ingrid ^bd,be   Westlye, Lars T ^bd,be   Gruber, Oliver ^bi,bj   Kraemer, Bernd ^bi,bj   Richter, Anja ^bi,bj   Zilles, David ^bj   Calhoun, Vince D ^k,l   Crespo Facorro, Benedicto ^bm,bo   Roiz Santiañez, Roberto ^bm,bo   Tordesillas Gutiérrez, Diana ^bm,bn,bo   Loughland, Carmel ^ak,an,ao   Carr, Vaughan J ^ai,ap   Catts, Stanley ^ar   Cropley, Vanessa L ^ah   Fullerton, Janice M ^ap,aq   Green, Melissa J ^ap,aq   Henskens, Frans A ^ak,al,an   Jablensky, Assen ^as   Lenroot, Rhoshel K ^ap,aq   Mowry, Bryan J ^ar   Michie, Patricia T ^am   Pantelis, Christos ^ah   Quidé, Yann ^ap,aq   Schall, Ulrich ^ak,am,an   Scott, Rodney J ^ak,an   Cairns, Murray J ^ak,an   Seal, Marc ^aj   Tooney, Paul A ^ak,an   Rasser, Paul E ^ak   Cooper, Gavin ^ak   Shannon Weickert, Cynthia ^ap,aq   Weickert, Thomas W ^ap,aq   Morris, Derek W ^bq,br   Hong, Elliot ^q   Kochunov, Peter ^q   Beard, Lauren M ^r   Gur, Raquel E ^r   Gur, Ruben C ^r   Satterthwaite, Theodore D ^r   Wolf, Daniel H ^r   Belger, Aysenil ^s,t   Brown, Gregory G ^g   Ford, Judith M ^u,v   Macciardi, Fabio ^a   Mathalon, Daniel H ^u,v   O'Leary, Daniel S ^w   Potkin, Steven G ^a   Preda, Adrian ^a   Voyvodic, James ^t   Lim, Kelvin O ^m   McEwen, Sarah ^p   Yang, Fude ^bs   Tan, Yunlong ^bs   Tan, Shuping ^bs   Wang, Zhiren ^bs   Fan, Fengmei ^bs   Chen, Jingxu ^bs   Xiang, Hong ^bt   Tang, Shiyou ^bt   Guo, Hua ^bu   Wan, Ping ^bu   Wei, Dong ^bv   Bockholt, Henry J ^l,w,x   Ehrlich, Stefan ^z,bk   Wolthusen, Rick P F ^y,z,bk   King, Margaret D ^l   Shoemaker, Jody M ^l   Sponheim, Scott R ^m,n   De Haan, Lieuwe ^au   Koenders, Laura ^au   Machielsen, Marise W ^au   van Amelsvoort, Therese ^ay   Veltman, Dick J ^at   Assogna, Francesca ^bw,bx   Banaj, Nerisa ^bw   de Rossi, Pietro ^bw,by   Iorio, Mariangela ^bw   Piras, Fabrizio ^bw,bx   Spalletta, Gianfranco ^ac,bw   McKenna, Peter J ^bo,bp   Pomarol Clotet, Edith ^bo,bp   Salvador, Raymond ^bo,bp   Corvin, Aiden ^br   Donohoe, Gary ^bq,br   Kelly, Sinead ^aa,ab   Whelan, Christopher D ^c   Dickie, Erin W ^cb   Rotenberg, David ^cb   Voineskos, Aristotle N ^cb   Ciufolini, Simone ^cc   Radua, Joaquim ^bg,bo,bp,cc   Dazzan, Paola ^cc,cd   Murray, Robin ^cc   Reis Marques, Tiago ^cc   Simmons, Andrew ^cc   Borgwardt, Stefan ^cg   Egloff, Laura ^cg   Harrisberger, Fabienne ^cg   Riecher Rössler, Anita ^cg   Smieskova, Renata ^cg   Alpert, Kathryn I ^ad   Wang, Lei ^ad   Jönsson, Erik G ^bd,bg   Koops, Sanne ^ax   Sommer, Iris E C ^aw   Bertolino, Alessandro ^bz   Bonvino, Aurora ^ca   Di Giorgio, Annabella ^ca   Neilson, Emma ^cf   Mayer, Andrew R ^l   Stephen, Julia M ^l   Kwon, Jun Soo ^ch,ci   Yun, Je Yeon ^ch,cj   Cannon, Dara M ^bq   McDonald, Colm ^bq   Lebedeva, Irina ^ck   Tomyshev, Alexander S ^ck   Akhadov, Tolibjohn ^cl   Kaleda, Vasily ^ck   Fatouros Bergman, Helena ^bg,bh,cu   Flyckt, Lena ^bg,bh,cu   Farde, Lars ^cu   Engberg, Göran ^cu   Erhardt, Sophie ^cu   Cervenka, Simon ^cu   Schwieler, Lilly ^cu   Piehl, Fredrik ^cu   Collste, Karin ^cu   Victorsson, Pauliina ^cu   Malmqvist, Anna ^cu   Hedberg, Mikael ^cu   Orhan, Funda ^cu   Busatto, Geraldo F ^cm   Rosa, Pedro G P ^cm   Serpa, Mauricio H ^cm   Zanetti, Marcus V ^cm   Hoschl, Cyril ^cn   Skoch, Antonin ^cn,co   Spaniel, Filip ^cn   Tomecek, David ^cn,cp   Hagenaars, Saskia P ^cf   McIntosh, Andrew M ^cf   Whalley, Heather C ^cf   Lawrie, Stephen M ^cf   Knöchel, Christian ^bl   Oertel Knöchel, Viola ^bl   Stäblein, Michael ^bl   Howells, Fleur M ^cq   Stein, Dan J ^cq,cr   Temmingh, Henk S ^cq   Uhlmann, Anne ^cq,cs   Lopez Jaramillo, Carlos ^ct   Dima, Danai ^cc,ce   McMahon, Agnes ^c   Faskowitz, Joshua I ^c   Gutman, Boris A ^ae   Jahanshad, Neda ^c   Thompson, Paul M ^c   Turner, Jessica A ^b,l   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^e University of California   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j HARTFORD HOSPITAL   (United States)

^k UNIVERSITY OF NEW MEXICO   (United States)

^l MIND RESEARCH NETWORK   (United States)

^m UNIVERSITY OF MINNESOTA   (United States)

ⁿ VA MEDICAL CENTER   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^t DUKE UNIVERSITY MEDICAL CENTER   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^w UNIVERSITY OF IOWA   (United States)

^x Advanced Biomedical Informatics Group LLC   (United States)

^y Social Neuroscience Laboratory   (United States)

^z MASSACHUSETTS GENERAL HOSPITAL   (United States)

^aa HARVARD MEDICAL SCHOOL   (United States)

^ab BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ac BAYLOR COLLEGE OF MEDICINE   (United States)

^ad NORTHWESTERN UNIVERSITY   (United States)

^ae Illinois Institute of Technology   (United States)

^af THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^ag UNIVERSITY OF MELBOURNE   (Australia)

^ah UNIVERSITY OF MELBOURNE   (Australia)

^ai MONASH UNIVERSITY   (Australia)

^aj MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^ak UNIVERSITY OF NEWCASTLE   (Australia)

^al UNIVERSITY OF NEWCASTLE   (Australia)

^am UNIVERSITY OF NEWCASTLE   (Australia)

^an HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^ao Hunter New England Area Health Service   (Australia)

^ap UNIVERSITY OF NEW SOUTH WALES   (Australia)

^aq NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^ar UNIVERSITY OF QUEENSLAND   (Australia)

^as UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^at VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^au UNIVERSITY OF AMSTERDAM   (Netherlands)

^av ERASMUS MEDICAL CENTER   (Netherlands)

^aw UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ax UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ay MAASTRICHT UNIVERSITY   (Netherlands)

^az NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^ba OSAKA UNIVERSITY   (Japan)

^bb OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^bc UNIVERSITY OF TOKYO   (Japan)

^bd UNIVERSITY OF OSLO   (Norway)

^be OSLO UNIVERSITY HOSPITAL   (Norway)

^bf DIAKONHJEMMET HOSPITAL   (Norway)

^bg KAROLINSKA INSTITUTE   (Sweden)

^bh STOCKHOLM COUNTY COUNCIL   (Sweden)

^bi UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^bj UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^bk DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^bl UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^bm HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^bn UNIVERSITY OF CANTABRIA   (Spain)

^bo CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^bp FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^bq NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^br TRINITY COLLEGE DUBLIN   (Ireland)

^bs BEIJING HUILONGGUAN HOSPITAL   (China)

^bt CHONGQING THREE GORGES UNIVERSITY   (China)

^bu Zhumadian Psychiatry Hospital   (China)

^bv Luoyang Fifth People's Hospital   (China)

^bw IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^bx MUSEO STORICO DELLA FISICA E CENTRO STUDI E RICERCHE ENRICO FERMI   (Italy)

^by SAPIENZA UNIVERSITY OF ROME   (Italy)

^bz UNIVERSITY OF BARI   (Italy)

^ca CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^cb CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^cc KING'S COLLEGE LONDON   (United Kingdom)

^cd SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^ce CITY UNIVERSITY   (United Kingdom)

^cf UNIVERSITY OF EDINBURGH   (United Kingdom)

^cg UNIVERSITY OF BASEL   (Switzerland)

^ch Seoul National University College of Medicine   (South Korea)

^ci Seoul National University   (South Korea)

^cj Seoul National University Hospital   (South Korea)

^ck MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^cl Department of Public Health of Moscow   (Russian Federation)

^cm UNIVERSITY OF SÃO PAULO   (Brazil)

^cn NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^co INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^cp CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

^cq UNIVERSITY OF CAPE TOWN   (South Africa)

^cr UNIVERSITY OF CAPE TOWN   (South Africa)

^cs STELLENBOSCH UNIVERSITY   (South Africa)

^ct UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^cu NONE

more..

Author keywords

Cortical; Imaging; Meta analysis; Schizophrenia; Surface area; Thickness

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN REGION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE DURATION; FEMALE; FRONTAL LOBE; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); NEUROIMAGING; ONSET AGE; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHIZOPHRENIA; SURFACE AREA; TEMPORAL LOBE; BRAIN; DIAGNOSTIC IMAGING; META ANALYSIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREFRONTAL CORTEX; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BRAIN; CASE-CONTROL STUDIES; CHILD; FEMALE; FRONTAL LOBE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; PREFRONTAL CORTEX; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE; YOUNG ADULT;

EID: 85049111550     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2018.04.023     Document Type: Article

References (72)

1. Goghari, V.M., Truong, W., Spilka, M.J., A magnetic resonance imaging family study of cortical thickness in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 168 (2015), 660–668.
2. Kuperberg, G.R., Broome, M.R., McGuire, P.K., David, A.S., Eddy, M., Ozawa, F., et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 60 (2003), 878–888.
3. Thompson, P.M., Schwartz, C., Toga, A.W., High-resolution random mesh algorithms for creating a probabilistic 3D surface atlas of the human brain. Neuroimage 3 (1996), 19–34.
4. Miller, M.I., Massie, A.B., Ratnanather, J.T., Botteron, K.N., Csernansky, J.G., Bayesian construction of geometrically based cortical thickness metrics. Neuroimage 12 (2000), 676–687.
5. Kabani, N., Le Goualher, G., MacDonald, D., Evans, A.C., Measurement of cortical thickness using an automated 3-D algorithm: A validation study. Neuroimage 13 (2001), 375–380.
6. Zijdenbos, A.P., Forghani, R., Evans, A.C., Automatic “pipeline” analysis of 3-D MRI data for clinical trials: Application to multiple sclerosis. IEEE Trans Med Imaging 21 (2002), 1280–1291.
7. Lerch, J.P., Evans, A.C., Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 24 (2005), 163–173.
8. Ad-Dab'bagh, Y., Einarson, D., Lyttelton, O., Muehlboeck, J.-S., Mok, K., Ivanov, O., et al. The CIVET image-processing environment: A fully automated comprehensive pipeline for anatomical neuroimaging research. Corbetta, M., (eds.) Proceedings of the 12th Annual Meeting of the Organization for Human Brain Mapping, 2006, NeuroImage, Florence, Italy.
9. Fischl, B., FreeSurfer. Neuroimage 62 (2012), 774–781.
10. Stein, J.L., Medland, S.E., Vasquez, A.A., Hibar, D.P., Senstad, R.E., Winkler, A.M., et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44 (2012), 552–561.
11. Thompson, P.M., Stein, J.L., Medland, S.E., Hibar, D.P., Vasquez, A.A., Renteria, M.E., et al. The ENIGMA Consortium: Large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 8 (2014), 153–182.
12. Thompson, P.M., Andreassen, O.A., Arias-Vasquez, A., Bearden, C.E., Boedhoe, P.S., Brouwer, R.M., et al. ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide. Neuroimage 145 (2017), 389–408.
13. Panizzon, M.S., Fennema-Notestine, C., Eyler, L.T., Jernigan, T.L., Prom-Wormley, E., Neale, M., et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex 19 (2009), 2728–2735.
14. Winkler, A.M., Kochunov, P., Blangero, J., Almasy, L., Zilles, K., Fox, P.T., et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 53 (2010), 1135–1146.
15. Rimol, L.M., Hartberg, C.B., Nesvåg, R., Fennema-Notestine, C., Hagler, D.J. Jr., Pung, C.J., et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry 68 (2010), 41–50.
16. van Haren, N.E.M., Schnack, H.G., Cahn, W., van den Heuvel, M.P., Lepage, C., Collins, L., et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry 68 (2011), 871–880.
17. Sugihara, G., Oishi, N., Son, S., Kubota, M., Takahashi, H., Murai, T., Distinct patterns of cerebral cortical thinning in schizophrenia: A neuroimaging data-driven approach. Schizophr Bull 43 (2017), 900–906.
18. Schultz, C.C., Koch, K., Wagner, G., Roebel, M., Nenadic, I., Schachtzabel, C., et al. Complex pattern of cortical thinning in schizophrenia: Results from an automated surface based analysis of cortical thickness. Psychiatry Res 182 (2010), 134–140.
19. Narr, K.L., Toga, A.W., Szeszko, P., Thompson, P.M., Woods, R.P., Robinson, D., et al. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry 58 (2005), 32–40.
20. Narr, K.L., Bilder, R.M., Toga, A.W., Woods, R.P., Rex, D.E., Szeszko, P.R., et al. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex 15 (2005), 708–719.
21. Fornito, A., Yücel, M., Wood, S.J., Adamson, C., Velakoulis, D., Saling, M.M., et al. Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp 29 (2008), 478–489.
22. Sun, D., Stuart, G.W., Jenkinson, M., Wood, S.J., McGorry, P.D., Velakoulis, D., et al. Brain surface contraction mapped in first-episode schizophrenia: A longitudinal magnetic resonance imaging study. Mol Psychiatry 14 (2009), 976–986.
23. Crespo-Facorro, B., Roiz-Santiáñez, R., Pérez-Iglesias, R., Rodriguez-Sanchez, J.M., Mata, I., Tordesillas-Gutierrez, D., et al. Global and regional cortical thinning in first-episode psychosis patients: Relationships with clinical and cognitive features. Psychol Med 41 (2011), 1449–1460.
24. Lesh, T.A., Tanase, C., Geib, B.R., Niendam, T.A., Yoon, J.H., Minzenberg, M.J., et al. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry 72 (2015), 226–234.
25. Baribeau, D.A., Anagnostou, E., A comparison of neuroimaging findings in childhood onset schizophrenia and autism spectrum disorder: A review of the literature. Front Psychiatry, 4, 2013, 175.
26. Ordóñez, A.E., Luscher, Z.I., Gogtay, N., Neuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings. Schizophr Res 173 (2016), 124–131.
27. Voets, N.L., Hough, M.G., Douaud, G., Matthews, P.M., James, A., Winmill, L., et al. Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. Neuroimage 43 (2008), 665–675.
28. Venkatasubramanian, G., Jayakumar, P.N., Gangadhar, B.N., Keshavan, M.S., Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia. Acta Psychiatr Scand 117 (2008), 420–431.
29. Rais, M., Cahn, W., Schnack, H.G., Hulshoff Pol, H.E., Kahn, R.S., van Haren, N.E.M., Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychol Med 42 (2012), 1847–1856.
30. Liu, X., Lai, Y., Wang, X., Hao, C., Chen, L., Zhou, Z., et al. A combined DTI and structural MRI study in medicated-naïve chronic schizophrenia. Magn Reson Imaging 32 (2014), 1–8.
31. van Lutterveld, R., van den Heuvel, M.P., Diederen, K.M.J., de Weijer, A.D., Begemann, M.J.H., Brouwer, R.M., et al. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain 137 (2014), 2664–2669.
32. Haller, S., Borgwardt, S.J., Schindler, C., Aston, J., Radue, E.W., Riecher-Rössler, A., Can cortical thickness asymmetry analysis contribute to detection of at-risk mental state and first-episode psychosis? A pilot study. Radiology 250 (2009), 212–221.
33. Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P.D., Wood, S.J., et al. Progressive brain structural changes mapped as psychosis develops in “at risk” individuals. Schizophr Res 108 (2009), 85–92.
34. Jung, W.H., Kim, J.S., Jang, J.H., Choi, J.-S., Jung, M.H., Park, J.-Y., et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull 37 (2011), 839–849.
35. Shin, K.S., Jung, W.H., Kim, J.S., Jang, J.H., Hwang, J.Y., Chung, C.K., Kwon, J.S., Neuromagnetic auditory response and its relation to cortical thickness in ultra-high-risk for psychosis. Schizophr Res 140 (2012), 93–98.
36. Tognin, S., Pettersson-Yeo, W., Valli, I., Hutton, C., Woolley, J., Allen, P., et al. Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis. Front Psychiatry, 4, 2013, 187.
37. Tognin, S., Riecher-Rössler, A., Meisenzahl, E.M., Wood, S.J., Hutton, C., Borgwardt, S.J., et al. Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis. Psychol Med 44 (2014), 489–498.
38. Cannon, T.D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T.G.M., et al. Progressive reduction in cortical thickness as psychosis develops: A multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry 77 (2015), 147–157.
39. Buchy, L., Barbato, M., Makowski, C., Bray, S., MacMaster, F.P., Deighton, S., Addington, J., Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study. Schizophr Res 189 (2017), 146–152.
40. van Erp, T.G.M., Hibar, D.P., Rasmussen, J.M., Glahn, D.C., Pearlson, G.D., Andreassen, O.A., et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 21 (2016), 547–553.
41. Okada, N., Fukunaga, M., Yamashita, F., Koshiyama, D., Yamamori, H., Ohi, K., et al. Abnormal asymmetries in subcortical brain volume in schizophrenia. Mol Psychiatry 21 (2016), 1460–1466.
42. Cahn, W., Rais, M., Stigter, F.P., van Haren, N.E.M., Caspers, E., Hulshoff Pol, H.E., et al. Psychosis and brain volume changes during the first five years of schizophrenia. Eur Neuropsychopharmacol 19 (2009), 147–151.
43. Gogtay, N., Weisinger, B., Bakalar, J.L., Stidd, R., Fernandez de la Vega, O., Miller, R., et al. Psychotic symptoms and gray matter deficits in clinical pediatric populations. Schizophr Res 140 (2012), 149–154.
44. Oertel-Knöchel, V., Knöchel, C., Rotarska-Jagiela, A., Reinke, B., Prvulovic, D., Haenschel, C., et al. Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrum. Cereb Cortex 23 (2013), 61–70.
45. Padmanabhan, J.L., Tandon, N., Haller, C.S., Mathew, I.T., Eack, S.M., Clementz, B.A., et al. Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. Schizophr Bull 41 (2015), 154–162.
46. Xiao, Y., Lui, S., Deng, W., Yao, L., Zhang, W., Li, S., et al. Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia. Schizophr Bull 41 (2013), 201–210.
47. Walton, E., Hibar, D.P., van Erp, T.G.M., Potkin, S.G., Roiz-Santiañez, R., Crespo-Facorro, B., et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatr Scand 135 (2017), 439–447.
48. Walton, E., Hibar, D.P., van Erp, T.G.M., Potkin, S.G., Roiz-Santiañez, R., Crespo-Facorro, B., et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychol Med 48 (2018), 82–94.
49. Navari, S., Dazzan, P., Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med 39 (2009), 1763–1777.
50. Fusar-Poli, P., Smieskova, R., Kempton, M.J., Ho, B.C., Andreasen, N.C., Borgwardt, S., Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev 37 (2013), 1680–1691.
51. Vita, A., De Peri, L., Deste, G., Barlati, S., Sacchetti, E., The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: Does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies. Biol Psychiatry 78 (2015), 403–412.
52. Kay, S.R., Fiszbein, A., Opler, L.A., The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987), 261–276.
53. Andreasen, N.C., Scale for the Assessment of Negative Symptoms: SANS. 1984, University of Iowa, Iowa City.
54. Andreasen, N., The Scale for the Assessment of Positive Symptoms (SAPS). 1984, University of Iowa, Iowa City.
55. Desikan, R.S., Ségonne, F., Fischl, B., Quinn, B.T., Dickerson, B.C., Blacker, D., et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31 (2006), 968–980.
56. Viechtbauer, W., Conducting meta-analyses in R with the metafor Package. J Stat Softw 36 (2010), 1–48.
57. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57 (1995), 289–300.
58. Thompson, P.M., Bartzokis, G., Hayashi, K.M., Klunder, A.D., Lu, P.H., Edwards, N., et al. Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb Cortex 19 (2009), 1107–1123.
59. Ho, B.-C., Andreasen, N.C., Ziebell, S., Pierson, R., Magnotta, V., Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68 (2011), 128–137.
60. Ansell, B.R., Dwyer, D.B., Wood, S.J., Bora, E., Brewer, W.J., Proffitt, T.M., et al. Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis. Psychol Med 45 (2015), 515–527.
61. Hedman, A.M., van Haren, N.E.M., van Baal, G.C.M., Brouwer, R.M., Brans, R.G.H., Schnack, H.G., et al. Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia. Schizophr Res 173 (2016), 192–199.
62. Lieberman, J.A., Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry, 62, 2005, 361.
63. Vernon, A.C., Crum, W.R., Lerch, J.P., Chege, W., Natesan, S., Modo, M., et al. Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs—linking magnetic resonance imaging findings to cellular pathology. Biol Psychiatry 75 (2014), 982–990.
64. Takahashi, T., Wood, S.J., Soulsby, B., McGorry, P.D., Tanino, R., Suzuki, M., et al. Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr Res 108 (2009), 49–56.
65. Lee, S.-H., Niznikiewicz, M., Asami, T., Otsuka, T., Salisbury, D.F., Shenton, M.E., McCarley, R.W., Initial and progressive gray matter abnormalities in insular gyrus and temporal pole in first-episode schizophrenia contrasted with first-episode affective psychosis. Schizophr Bull 42 (2016), 790–801.
66. Takahashi, T., Wood, S.J., Yung, A.R., Phillips, L.J., Soulsby, B., McGorry, P.D., et al. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res 111 (2009), 94–102.
67. Sowell, E.R., Peterson, B.S., Thompson, P.M., Welcome, S.E., Henkenius, A.L., Toga, A.W., Mapping cortical change across the human life span. Nat Neurosci 6 (2003), 309–315.
68. Birnbaum, R., Weinberger, D.R., Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci 18 (2017), 727–740.
69. Chen, E.Y., Hui, C.L., Lam, M.M., Chiu, C.P., Law, C.W., Chung, D.W., et al. Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: Randomised controlled trial. BMJ, 341, 2010, c4024.
70. Tiihonen, J., Walhbeck, K., Lönnqvist, J., Klaukka, T., Ioannidis, J.P.A., Volavka, J., Haukka, J., Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: Observational follow-up study. BMJ, 333, 2006, 224.
71. Hibar, D.P., Westlye, L.T., Doan, N.T., Jahanshad, N., Cheung, J.W., Ching, C.R.K., et al. Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry 23 (2018), 932–942.
72. Schmaal, L., Hibar, D.P., Sämann, P.G., Hall, G.B., Baune, B.T., Jahanshad, N., et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry 22 (2017), 900–909.